Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Sterling Biotech bank...

    Sterling Biotech bank fraud case,ED attaches property worth 4700 crores

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-12-08T10:20:13+05:30  |  Updated On 8 Dec 2018 10:20 AM IST
    Sterling Biotech bank fraud case,ED attaches property worth 4700 crores

    New Delhi: The Enforcement Directorate (ED) on Friday, after a seven-month-long probe, attached several movable and immovable properties worth more than Rs. 4,700 crores in connection with the Sterling Biotech group bank loan fraud case.


    The properties were attached under the provisions of the Prevention of Money Laundering Act (PMLA), 2002.


    The crackdown was carried out on the basis of an FIR that was registered in October 2017 against the Vadodara-based Sterling Biotech Limited.


    The attached assets include nearly 4,000 acres of properties, luxury cars, nearly 200 bank accounts of various companies and shares worth more than Rs. 6.50 crores.


    It is alleged that Sterling's promoters, on the basis of false and fabricated documents, fraudulently obtained credit facilities of more than Rs. 5,000 crores from various banks, which subsequently were turned into Non-Performing Assets (NPAs).


    During the investigation, the Special PMLA Court issued non-bailable warrants against the company's promoters Nitin and Chetan Sandesara.


    The probe revealed that the promoters set up more than 300 shell and benami companies in India and abroad to divert and misutilise loan funds, manipulate balance sheets and fudging other documents to inflate turnovers and insider shares trading.


    The Sandesaras reportedly controlled these shell and benami companies through dummy directors, who were shown as employees of various companies of the Sterling Group.


    Information available in the public domain indicate that bogus sale/purchase was shown between the benami companies and the Sterling Group of companies to facilitate diversion of loan funds and inflate turnovers to obtain further bank loans.


    These loans were then rotated in multiple layers through various shell and benami companies to conceal the original source from where funds were collected.


    The Enforcement Directorate achieved a major breakthrough in the case when it recovered truckloads of material from a room in the Jogeshwari area of Mumbai that provided information on how various shell and benami companies were formed and managed. The seized material included original chequebooks, rubber stamps, company seals, original property documents, original PAN cards, and more than 10 lakh pages of other incriminating documents.


    In total, the Enforcement Directorate has carried out more than 50 searches at various premises in several cities, including Delhi-NCR, Mumbai, Vadodara, Ahmedabad and Surat.


    The syphoned off loan funds were used to buy properties in the names of various companies, to purchase shares of Sterling Biotech Ltd and Sterling International Enterprises Ltd to attract investors. Some of the diverted loan funds were also paid to public servants. The Enforcement Directorate is also investigating various cross-border transactions undertaken by the group.


    It is being reported that over 50 foreign bank accounts and several other assets and properties situated abroad linked to the Sterling Group are under the ED's scanner.


    So far, the ED has arrested Delhi based businessman Gagan Dhawan, former Andhra Bank director Anup Garg and Sterling Biotech Ltd. director Rajbhushan Dixit.


    Also Read: ED Files fresh charge sheet in Rs 50-billion Sterling Biotech scam
    EDEnforcement DirectorateFIRNon-Performing AssetsPMLAPrevention of Money Laundering ActSterling BiotechSterling Biotech Group
    Source : ANI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok